Market research
NSPR InspireMD Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 41M
- P/E ratio
- Not available
- Analyst target
- 3.3333
- Dividend yield
- Not available
- Beta
- 0.77
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US45779A8466
- Market cap
- 41M
- P/E ratio
- Not available
- Analyst target
- 3.3333
- Dividend yield
- Not available
- Beta
- 0.77
About
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the NSPR discussion.
5 years, 4 months ago
InspireMD, Inc is currently in a long term downtrend where the price is trading 39.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.0.
InspireMD, Inc's total revenue sank by 84.4% to $158K since the same quarter in the previous year.
Its net income has dropped by 50.7% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 39.5% to $-2M since the same quarter in the previous year.
Based on the above factors, InspireMD, Inc gets an overall score of 1/5.